Blincyto 35MCG VL w-stabilizers
Ended Awarded
- Contract number
- SPE2DB25FKE53
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $66,673
Award facts
- Contract value 100% obligated
- $66,673.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $66,673.40 to AmerisourceBergen Drug Corp for BLINCYTO 35 MCG vials with stabilizers on September 29, 2025. This firm fixed price, non-competitive delivery order is scheduled for completion by October 21, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. BLINCYTO (blinatumomab) is a bispecific monoclonal antibody used in the treatment of certain blood cancers, and this delivery supports the federal government's pharmaceutical supply chain for military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical prime vendor agreement running through December 2026. This prime IDC enables AmerisourceBergen to supply a broad spectrum of pharmaceutical products and medical supplies globally to support military healthcare programs, including specialty medications, vaccines, and medical devices. The contract demonstrates AmerisourceBergen's critical role in the Defense Logistics Agency's medical supply chain, serving entities including the Defense Health Agency and U.S. Coast Guard through a flexible contracting mechanism designed to ensure reliable access to essential medications across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FKE53?
SPE2DB25FKE53 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 29, 2025.
How much is contract SPE2DB25FKE53 worth?
The government has obligated $66,673 on SPE2DB25FKE53.
Is contract SPE2DB25FKE53 an order under another contract?
Yes. SPE2DB25FKE53 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FKE53 competed?
The extent of competition for SPE2DB25FKE53 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award